Equity Details
Price & Market Data
Price: $1.33
Daily Change: -$0.005 / 0.38%
Daily Range: $1.30 - $1.39
Market Cap: $150,768,128
Daily Volume: 358,898
Performance Metrics
1 Week: 3.05%
1 Month: -0.74%
3 Months: 25.00%
6 Months: 32.35%
1 Year: 19.47%
YTD: 41.54%
About Cardiol Therapeutics Inc. (CRDL)
Data on Cardiol Therapeutics Inc. (CRDL). Price: 1.33, daily change: -$0.005 / 0.38%. Market cap: 150,768,128. Performance YTD and 1-year.
Company Details
Employees: 23
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.